VARINDER JINDAL: Open Payments
NPI 1558092221 · SIMPSONVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$790 in 34 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $97 · 2025 $790
Food & beverage: $790
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $332 |
| AstraZeneca Pharmaceuticals LP | 10 | $202 |
| Amgen Inc. | 4 | $83 |
| Novo Nordisk Inc | 2 | $48 |
| Dexcom, Inc. | 2 | $47 |
| ABIOMED | 1 | $41 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $17 |
Products named: Kerendia, BREZTRI, OTEZLA, Ozempic, Dexcom G6 Transmitter, FARXIGA, AIRSUPRA, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
